[1]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[2]
Casey RG, Catto JWF, Cheng L, et al. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: A systematic review. Eur Urol 2015; 67: 876-88.
[3]
Sylvester RJ, Oosterlinck W, Holmang S, et al. Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: Which patients benefit from the instillation? Eur Urol 2016; 69: 231-44.
[4]
Zhang D, Sun P, Li P, et al. A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer. Biomaterials 2013; 34: 10258-66.
[5]
Tan J, Sun C, Xu K, Wang C, Guo J. Immobilization of ALA-Zn-II coordination polymer pro-photosensitizers on magnetite colloidal supraparticles for target photodynamic therapy of bladder cancer. Small 2015; 11: 6338-46.
[6]
Vila-Caballer M, Codolo G, Munari F, et al. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment. J Control Release 2016; 238: 31-42.
[7]
Teles Ferreira J, Pina J, Fontes Ribeiro CA, et al. PEG-containing ruthenium phthalocyanines as photosensitizers for photodynamic therapy: synthesis, characterization and in vitro evaluation. J Mater Chem B 2017; 5: 5862-9.
[8]
Guo H, Xu W, Chen J, et al. Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma. J Control Release 2017; 259: 136-48.
[9]
Guo H, Li F, Xu W, et al. Mucoadhesive cationic polypeptide nanogel with enhanced penetration for efficient intravesical chemotherapy of bladder cancer. Adv Sci 2018; 5(6): 1800004.
[10]
Oliveira MB, da Silva JB, Montanha MC, Kimura E, Diniz A, Bruschi ML. Design and characterization of mucoadhesive gelatin-ethylcellulose microparticles for the delivery of curcumin to the bladder. Curr Drug Deliv 2018; 15: 1112-22.
[11]
Kaldybekov DB, Tonglairoum P, Opanasopit P, Khutoryanskiy VV. Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder. Eur J Pharm Sci 2018; 111: 83-90.
[12]
Guo H, Wang J, He L, Hou Y, Ding J. Targeting polyion complex micelle intracellularly delivers protein drug toward orthotopic bladder cancer. Nanomed Nanotech Bio Med 2018; 14: 1883.
[13]
Guo H, Xu W, Wang J, He L, Hou Y, Ding J. Engineered nanogel with superior tissue affinity and cell targeting toward orthotopic bladder cancer. J Control Release 2017; 259: e48-9.
[14]
Pandey R, Jackson JK, Mugabe C, Liggins R, Burt HM. Tissue permeability effects associated with the use of mucoadhesive cationic nanoformulations of docetaxel in the bladder. Pharm Res 2016; 33: 1850-61.
[15]
Kos MK, Bogataj M, Veranic P, Mrhar A. Permeability of pig urinary bladder wall: Time and concentration dependent effect of chitosan. Biol Pharm Bull 2006; 29: 1685-91.
[16]
GuhaSarkar S, More P, Banerjee R. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery. J Control Release 2017; 245: 147-56.
[17]
Mikolajczyk A, Khosrawipour V, Schubert J, et al. Feasibility and characteristics of pressurized aerosol chemotherapy (PAC) in the bladder as a therapeutical option in early-stage urinary bladder cancer. In Vivo 2018; 32: 1369-72.
[18]
Nowacki M, Peterson M, Kloskowski T, et al. Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis. Oncotarget 2017; 8: 78208-24.
[19]
Douat C, Aisenbrey C, Antunes S, et al. A cell-penetrating foldamer with a bioreducible linkage for intracellular delivery of DNA. Angewandte Chemie-International Edition 2015; 54: 11133-7.
[20]
Zhang N, Yan Z, Zhao X, Chen Q, Ma M. Efficient mini-transporter for cytosolic protein delivery. Acs Applied Mat Inter 2016; 8: 25725-32.
[21]
Bohle A, Jurczok A, Ardelt P, et al. Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J Urol 2002; 167: 357-63.
[22]
Oliva N, Carcole M, Beckerman M, et al. Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia. Sci Transl Med 2015; 7(272): 272ra11.
Related Journals
Current Drug Safety
Current Medicinal Chemistry
Current Neuropharmacology
Current Pharmaceutical Analysis
Current Topics in Medicinal Chemistry
Current Vascular Pharmacology
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
CNS & Neurological Disorders - Drug Targets
Related Books
New Findings from Natural Substances
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Frontiers in Clinical Drug Research – Anti Allergy Agents
Pharmaceuticals for Targeting Coronaviruses
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Frontiers in Inflammation
Article Metrics
28
7